Skip to content
MedsAcross

Medicine

Amiodarone 400 mg tablet

Amiodarone · Oral
Available on requestPrescription onlyUS FDAGeneric name

Amiodarone 400 mg tablet is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F). Protect from light.

Key facts

Active ingredient (INN)
Amiodarone
Brand
Sold under the generic name
Strength
400 mg
Dosage form
Tablet
Route
Oral
Packs
30 tablets, 10 blister pack and 3 more
Manufacturers
Sun Pharmaceutical IndustriesIndiaZydus LifesciencesIndiaAdvagen PharmaChartwell RX
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F). Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C01BD01 Amiodarone
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
29 November 2002
Identifiers
RxCUI 833528, 834348, 835956 +1DailyMed set ID 3e8db251-e3c5-4fba-be9a-6044a92f0beb, b41cbcb5-9c5d-4e45-a4f2-952df5f22c00, 5520f11d-968d-4f4f-bf57-d14369c0d746 +2NDC 65841-841, 68382-298, 62135-578 +2Application ANDA079029, ANDA077069, ANDA078578 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
30 tablet in 1 bottle65841-841-06Zydus LifesciencesIndia9 February 2023
30 tablet in 1 bottle68382-298-06Zydus LifesciencesIndia9 February 2023
10 blister pack in 1 carton / 10 tablet in 1 blister pack51672-4057-0Sun Pharmaceutical IndustriesIndia29 November 2002
30 tablet in 1 bottle51672-4057-6Sun Pharmaceutical IndustriesIndia29 November 2002
30 tablet in 1 bottle72888-061-30Advagen Pharma21 August 2020
30 tablet in 1 bottle62135-578-30Chartwell RX17 August 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 24 December 1985Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Amiodarone 400 mg tablet.

Compare 1

Other strengths and forms of Amiodarone

Clinical summary

Amiodarone is an antiarrhythmic indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy. MedsAcross supplies Amiodarone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Amiodarone

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Amiodarone 400 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.